Companies
Helaina
founded in New York by Laura Katz in 2019, Helaina brews human-identical lactoferrin (effera) in Komagataella phaffii and has published 11 papers on it; production has reached metric-ton scale (about 10 million servings per run) through co-manufacturing partners,…
- Country
- United States
FDA GRAS (self-affirmed)
Coverage
| CN | EU | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsfdaefsa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $83 million total equity funding (including $45 million Series B) (2024-09-25) | edibleplanetventures.com |
| Capacity | metric tons per production run (10 million servings per run) | agfundernews.com · foodnavigator.com |
| Certification | self-affirmed GRAS status in the US | agfundernews.com · foodnavigator.com |
| Regulatory approval | US GRAS status secured; European and other major market approvals in progress medium confidence | foodnavigator.com |
| Production site | 15,000 square foot R&D facility in Midtown Manhattan, New York City | blog.priceplow.com |
| Headcount | 43 employees (2024-12-31) medium confidence | fsome.com · datanyze.com · thecompanycheck.com |
Independent sources: agfundernews.com · blog.priceplow.com · datanyze.com · edibleplanetventures.com · foodnavigator.com · fsome.com · thecompanycheck.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Precision-fermented infant formula | food-alt-protein | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.